105
Participants
Start Date
January 17, 2019
Primary Completion Date
October 12, 2021
Study Completion Date
October 12, 2021
Levonorgestrel 52 mg intrauterine system
Levonorgestrel 52 mg intrauterine system
Magee-Womens Hospital, Center for Family Planning, Pittsburgh
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Johns Hopkins Bayview Medical Center, Baltimore
Eastern Virginia Medical-Conrad Clinical Research Center, Norfolk
M3 Wake Research, Inc., Raleigh
Emory University School of Medicine, Atlanta
WR-Mount Vernon Clinical Research, LLC, Sandy Springs
WR-Medical Research Center of Memphis, Memphis
UF Health Women's Specialists, Jacksonville
Comprehensive Clinical Trials, LLC, West Palm Beach
WR-ClinSearch, LLC, Chattanooga
University of Tennessee Medical Center, Knoxville
The Ohio State University, Columbus
University Hospitals Cleveland Medical Center, Cleveland
University of Cincinnati Physicians Company, Cincinnati
University of Michigan Women's Hospital, Ann Arbor
Washington University in St. Louis School of Medicine, St Louis
Baylor College of Medicine, Houston
University of Colorado Denver, Aurora
CR Prime, Idaho Falls
University of Utah, Salt Lake City
MomDoc Women's Health Research, Scottsdale
Rex Garn Mabey, Las Vegas
Wr-McCr, Llc, San Diego
Stanford University Medical Center, OB-GYN Clinic, Stanford
OB/GYN Research, University of California, Davis Health, Sacramento
Oregon Health and Science University, Portland
Women's Health Research Center, Lawrenceville
Lead Sponsor
Medicines360
OTHER